Twitter Facebook Youtube

Pay-for-Delay: A Costly Practice in the Pharmaceutical Industry

02.05.2013
~ Comments (0)

As U.S. health care costs continue to increase, the cost of prescription drugs are often a topic of debate surrounding health care reform discussions. Last year, prescription drug expenditures exceeded $326 billion, which accounted for approximately 11% of total health care expenditures in the U.S.1 With costs only expected to increase over the next several [...]

Tags : , , ,

Photograph taken by Gustau Nacarino (Reuters).

Revisiting the Ban on Federal Funding for Syringe Exchange Programs

06.04.2013
~ Comments (0)

With HIV infection rates persisting at high levels in the United States, it’s time we faced the facts. Science and policy are disconnected. In the United States, the sharing of contaminated needles during injection drug use accounts for 7-14% of new HIV infections each year.

Tags : ,

How the ACA affects low-income Americans

08.12.2012
~ Comments (0)

HHPR hosted an open lunch with Professor Benjamin Sommers, M.D., Ph.D.  December 7, 2012 1:00PM-2:00PM Eliot Memorial Dining Hall   Benjamin Sommers, M.D., Ph.D is an Assistant Professor of Health Policy and Economics at the Harvard School of Public Health. His research focuses on addressing barriers to care for low-income Americans and the uninsured especially [...]

Celebrating the launch of Student Mental Health Policy Issue, Spring 2012.

03.12.2012
~ Comments (0)

HHPR hosted an open Student Mental Health Policy Panel December 3, 2012 7:30PM-9:00PM Eliot JCR Featuring Distinguished Speakers:  Dr. Paul Barreira Director, Harvard UHS Dr. Catherine Bell Coordinator of College Mental Health Program, McLean Hospital Dr. David Rosmarin Department of Psychiatry, Harvard Medical School   The speakers’ presentations were followed by a wonderful open discussion with [...]

Rethinking Pay-for-Performance

28.11.2012
~ Comments (0)

The cost of health care in the U.S. is spiraling out of control. One of the many contributing factors to escalating costs often cited by health policy experts is the fee-for-service payment system. FFS rewards providers based on the quantity rather than the quality of care delivered. As a result, our country suffers from widespread overutilization of medical services…

Tags : , ,

Introducing HHPR Online Blog

26.11.2012
~ Comments (0)

Welcome to the Harvard Health Policy Review’s Blog! This is a forum for staff members of the Harvard Health Policy Review to discuss and comment on all things concerning health policy from an interdisciplinary perspective. Topics will include but are not limited to health care, economics, medical sociology, bioethics, drug development, and political analysis. We hope to bring you interesting [...]

Spring 2012 Issue: Student Mental Health

18.06.2012
~ Comments (0)

Check out our latest issue on mental health on college campuses in “Current Publications.”

HHPR now indexed in EBSCO

18.06.2012
~ Comments (0)

We are proud to inform you that HHPR is now a member journal in the EBSCO Research Database, an inclusion which allows us to appeal to a wider, more global readership.

HHPR Online

18.06.2012
~ Comments (0)

Welcome to the redesigned HHPR Online, complete with full PDF access to current and past issues.

Footer Left Links
Footer Right LInks

Recent Blog Posts

  • As U.S. health care costs continue to increase, the cost of prescription drugs are often a topic of debate surrounding health care reform discussions. Last

  • With HIV infection rates persisting at high levels in the United States, it’s time we faced the facts. Science and policy are disconnected. In the United States, the sharing of contaminated needles during injection drug use accounts for 7-14% of new HIV infections each year.

learn more...

Quick Contact

Twitter Facebook Youtube

A Publication of the Harvard Interfaculty Initiative in Health Policy

Copyright � 2013 Harvard Health Policy Review

WordPress Web Design by Themes4CMS.com